U.S. markets closed

Teladoc Health, Inc. (TDOC)

NYSE - NYSE Delayed Price. Currency in USD
18.59+0.06 (+0.32%)
At close: 04:00PM EDT
18.60 +0.01 (+0.05%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Inside Bar (Bullish)

Inside Bar (Bullish)

Previous Close18.53
Bid18.52 x 2200
Ask18.58 x 900
Day's Range18.51 - 19.08
52 Week Range18.47 - 34.73
Avg. Volume5,603,649
Market Cap3.066B
Beta (5Y Monthly)1.10
PE Ratio (TTM)N/A
EPS (TTM)-24.33
Earnings DateOct 24, 2023 - Oct 30, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est29.39
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for TDOC

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Teladoc Health, Inc.
    Analyst Report: Teladoc Health IncTeladoc Health Inc., based in Purchase, New York, provides telemedicine virtual healthcare services in the United States and internationally. Customers can speak to licensed physicians about non-emergency care, mental health, and dermatological conditions, and receive remote prescriptions for medication. Clients sign up for yearly or monthly subscriptions, and may also pay a flat fee for an appointment. Teladoc's consulting physicians are paid per consult. Founded in 2002, the company has grown into one of the largest virtual healthcare platforms in the United States. Since its IPO in 2015, the company has increased its membership, product offerings, and the utilization of its services.
    Fair Value
    Economic Moat
    2 months agoArgus Research
View more
  • Motley Fool

    2 Stocks Under $25 to Buy and Hold for 10 Years

    The company's current lineup includes the t:slim X2 and the newly cleared Mobi Insulin Pump, which management calls "the world's smallest durable insulin delivery system." Despite this progress on the regulatory front, Tandem has been bruised and battered on the stock market over the past year, as its financial results haven't been as good. The company's sales of insulin pumps have declined amid the challenging economy, leading to lower year-over-year revenue growth.

  • Zacks

    Here's Why Hold Strategy is Apt for Teladoc (TDOC) Stock Now

    Teladoc's (TDOC) BetterHelp business is expected to gain from new member growth and stable customer acquisition costs.

  • Motley Fool

    2 Top Growth Stocks Down 16% and 43% to Invest $1,000 in Right Now

    These companies haven't performed at pandemic levels, but investors may be overlooking some key green flags.